Medical Oxygen Concentrators & Oxygen Cylinders Market Share, Size, Trends, Industry Analysis Report, By Product (Portable Concentrator, Stationary Concentrator, Cylinders); By Technology (Continuous Flow, Pulse Flow); By End-users (Homecare, Non-homecare); By Regions; Segment Forecast, 2021 - 2028

Report Summary

2020年全球医疗氧气浓缩器和氧气气瓶市场的价值为320亿美元，预计预测期内的复合年增长率为3.1％。随着人群不断增长的，慢性阻塞性肺病（COPD）正在崛起，影响数百万人，并指示未来对氧气浓缩器和气缸的需求增加。由于Covid-19，呼吸系统问题的患者的数量显着增加，预计这一流行病的影响将持续更长时间，导致市场增长迅速。

Know more about this report:request for sample pages

The rising prevalence of COPD and other lung disorders is an important factor driving the demand in the market for medical O₂集中器＆O.₂汽缸。烟草吸烟者和容易机载毒素的个人具有更高的COPD和其他类型的肺病患者。

COPD is a major cause of death and morbidity around the world. COPD became the fourth most common cause of morbidity and mortality in 2019, according to the European Respiratory Society, and is forecast to be the third most common cause of morbidity and mortality over the next ten years if prevalence continues to rise at the same rate.

此外，由于呼吸机的全球稀缺，Covid-19爆发对氧气浓缩器和气瓶市场直接影响。为了解决这一短缺，生物医学工程师和研究人员已经创建了即兴的设备，通过重新修复麻醉机，氧气集中器，手动复苏器和PAP器件等现有设备来模仿呼吸机的基本功能。

行业动态

Growth Drivers
医用氧气浓缩器和氧气气缸主要用于治疗呼吸系统并发症，如在COPD的情况下。COPD是全球死亡率的主要原因之一，全球影响超过2.7亿。支气管炎在美国的450万人中影响了890万人。45岁的人中检测到75％的病例。

Most COPD will have severe breathing difficulties and they require oxygen support in their treatment regimen. More than 7 million people get admitted to U.S. hospitals in emergency and hence increasing incidence of lung disorders and COPD will be the key factors that will drive the demand for oxygen concentrators and cylinders.

Covid-19大流行预计将在预测期间大大加快全球集中器和气缸市场的增长。近1.5亿个Covid-19案件在世界各地诊断出来，到4月2021年，在很多地区，没有令人放缓的大流行迹象。东南亚目睹了大量案例，缺乏医疗保健基础设施，包括o的短缺₂.

Coronavirus mainly targets lungs in the affected patients leading to many respiratory complications. This has resulted in an unprecedented level of demand for O₂concentrators and cylinders across the globe. The governments are investing a huge amount of money to increase O₂集中器和油缸产品ion. According to WHO, every day over 1 million cylinders of O₂is required to combat the COVID-19 pandemic in low-and middle-income countries of the world.

许多新产品已被市场上的各种玩家推出。例如，自由式舒适便携式氧气集中器于2019年推出了凯尔。该系统与AutoStart技术集成，有助于将氧气推注始终如一，因为患者在其日常生活中波动。

In 2019, iGo2 Portable Oxygen Concentrator was launched by Drive DeVilbiss Healthcare that has the ability to adjust automatically and will provide a dosage of oxygen based on the breath rate of the patient. It is used in the treatment of emphysema, chronic bronchitis, and COPD.

Medical Oxygen Concentrators & Oxygen Cylinders Market Scope

该市场主要基于产品，技术，最终用户和地区分段。

By Product	通过技术	通过最终用户	按地区
Portable Concentrator Stationary Concentrator Cylinders	连续流动 脉冲流量	homecare. 非主页	North America (U.S., Canada) Europe (France, Germany, Italy, Spain, UK, Netherlands, Austria) 亚太地区（中国，印度，日本，印度尼西亚，马来西亚，韩国） Latin America (Argentina, Brazil, Mexico) Middle East & Africa (Saudi Arabia, UAE, South Africa, Israel)

Know more about this report:request for sample pages

产品洞察力

便携式医疗集中器在2020年产生了最高的收入，由于呼吸道疾病等哮喘，肺炎和COPD的患病率升高，预计在预测时间范围内增加了这些设备。此外，该部分预计将通过增加空中旅行者数量的增加以及来自联邦航空管理局（FAA）的产品的越来越多的批准。

预计静止医疗集中器的市场段预计将以比便携式设备的速度增长较慢。这些医疗装置是由老年人的流动性的优选。因此，它在具有大型人口的国家变得更加流行。

此外，由于静止的医疗集中器更具成本效益，因此其使用在欠发达和发展中经济体中的使用增加。O.₂cylinders are predicted to grow significantly during the forecast timeframe. The purity of the O₂supplied by these devices, as well as their compact configuration, are key factors supporting their growth.

技术洞察力

The continuous flow segment generated the highest market revenue in 2020. Advancement in technology in the development of new products is anticipated to increase the use of medical O₂concentrators. Moreover, the continued use of respiratory equipment for O₂治疗计划推动市场市场增长。

Continuous flow O₂集中器主要销售到年龄和屋狗患者。此外，设备没有与任何呼吸检测技术连接，使其比脉冲流技术便宜。

由于技术进步，预测脉冲流技术预测在预测时限2021-2028期间显着增长。该技术最适合领导活跃生活方式的用户。因此，工作专业人员，频繁的空中旅行者和患有COPD的运动员或任何其他呼吸问题越来越多地转向依靠这项技术的集中器。

地理概述

沙北美占最大的市场re of the global medical oxygen concentrators & oxygen cylinders during the forecast period. The region has modern healthcare facilities, and it has resulted in the availability of sophisticated healthcare devices.

In the U.S. alone, over 16 million people are suffering from COPD which is expected to be the main driving factor for the market growth of the medical oxygen concentrators & oxygen cylinders market and the U.S. is the worst COVID-19 hit country across the globe with over 32 million cases detected, by April 2021.

Asia Pacific is expected to be the fastest-growing region for the global medical oxygen concentrators & oxygen cylinders market during the forecast period owing to an increase in respiratory diseases such as COPD. In China, COPD is the third leading cause of mortality and the incidence rate is nearly 70 per 100,000 population. The region is one of the worst-hit places of the COVID-19 pandemic.

India is recording over 100,000 cases per day, as of, April 2021, which is the highest for any country in the world in the pandemic period. The government is investing significantly to procure medical O₂concentrators and cylinders to meet the huge market demand of hospitals. The government has allotted around USD 26 million to set up 162 PSA O₂集中器植物在国家的32个州。政府还削减了进口医疗集中者的所有关税。

Competitive Insight

Most of the medical device manufacturing companies are focusing on the production of O₂concentrators and cylinders owing to a huge number of COVID-19 cases being diagnosed every day across the globe. Companies are also focusing to develop innovative devices to treat respiratory disorders to gain a competitive advantage over their market rivals.

Some of the major players operating in the market for medical oxygen concentrators & oxygen cylinders include Koninklijke Philips N.V. (Philips Resipronics), CAIRE INC., Drive DeVilbiss Healthcare Inc., Invacare Corporation, Inogen Inc., Nidek Medical Products, Inc., O2 Concepts, LLC, OxyGo, LLC, Precision medical, Inc., ResMed, Linde plc, GCE Group (GCE Healthcare) and Cramer Decker Medical, Inc.